Danimer Scientific, Inc.
DNMR
$1.13
-$0.165-12.74%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -26.70% | -21.40% | -10.75% | -12.28% | -8.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -26.70% | -21.40% | -10.75% | -12.28% | -8.20% |
| Cost of Revenue | -14.55% | -5.16% | 9.40% | 16.35% | 13.75% |
| Gross Profit | -15.36% | -42.83% | -88.67% | -211.61% | -176.57% |
| SG&A Expenses | -44.88% | -33.95% | -25.09% | -14.81% | -16.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.03% | -20.49% | -10.86% | -2.99% | -5.37% |
| Operating Income | 29.98% | 20.13% | 10.90% | -1.00% | 4.16% |
| Income Before Tax | 22.69% | 35.23% | 23.57% | 14.07% | 13.74% |
| Income Tax Expenses | -97.08% | 210.23% | 167.49% | 139.38% | 110.63% |
| Earnings from Continuing Operations | 22.83% | 34.85% | 23.11% | 13.51% | 12.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.83% | 34.85% | 23.11% | 13.51% | 12.22% |
| EBIT | 29.98% | 20.13% | 10.90% | -1.00% | 4.16% |
| EBITDA | 39.70% | 28.66% | 18.93% | 7.42% | 15.44% |
| EPS Basic | 27.53% | 36.87% | 23.90% | 14.25% | 12.92% |
| Normalized Basic EPS | 23.71% | 7.11% | -14.72% | -32.59% | -39.80% |
| EPS Diluted | 27.53% | 36.87% | 23.90% | 14.25% | 12.92% |
| Normalized Diluted EPS | 23.71% | 7.11% | -14.72% | -32.59% | -39.80% |
| Average Basic Shares Outstanding | 8.60% | 4.47% | 1.12% | 0.90% | 0.97% |
| Average Diluted Shares Outstanding | 8.60% | 4.47% | 1.12% | 0.90% | 0.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
